Related Experiment Video

Updated: May 12, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Uremic cardiomyopathy: an underdiagnosed disease

Eyad Alhaj1, Nehad Alhaj, Ifad Rahman

  • 1Department of Cardiology, UMDNJ, New Jersey Medical School, Newark, NJ 07103, USA. Eyadalhaj@yahoo.com

Congestive Heart Failure (Greenwich, Conn.)
|April 26, 2013
PubMed

Insights

Uremic cardiomyopathy, common in chronic kidney disease (CKD) and end-stage renal disease (ESRD), may be slowed by early hemodialysis. Kidney transplantation offers significant survival benefits and can reverse this condition.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Uremic cardiomyopathy significantly increases morbidity and mortality in chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
  • Early intervention is crucial for managing this condition.

Purpose of the Study:

  • To review the impact of hemodialysis and kidney transplantation on uremic cardiomyopathy.
  • To explore potential future therapeutic targets.

Main Methods:

  • Literature review of studies on hemodialysis (conventional and frequent) and kidney transplantation in CKD/ESRD patients.
  • Analysis of data on uremic cardiomyopathy progression and reversal.

Main Results:

  • Early hemodialysis may halt the progression of uremic cardiomyopathy.
  • Frequent hemodialysis shows potential advantages over conventional hemodialysis.
  • Kidney transplantation can reverse uremic cardiomyopathy and improve survival.

Conclusions:

  • Hemodialysis and kidney transplantation are key interventions for uremic cardiomyopathy in CKD/ESRD.
  • Future therapies should focus on cellular mechanisms to reduce the burden of uremic cardiomyopathy.

More Related Videos

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...